1
|
Wood R, Tembele W, Hema A, Somé A, Kinganda-Lusamaki E, Basilubo C, Lumembe R, Alama N, Mbunsu G, Zongo A, Ahuka S, Muyembe JJ, Leendertz F, Eckmanns T, Schubert G, Kagoné T, Makiala S, Tomczyk S. Implementation of the WHO core components of an infection prevention and control programme in two sub-saharan African acute health-care facilities: a mixed methods study. Antimicrob Resist Infect Control 2024; 13:4. [PMID: 38221629 PMCID: PMC10789048 DOI: 10.1186/s13756-023-01358-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Accepted: 12/18/2023] [Indexed: 01/16/2024] Open
Abstract
BACKGROUND The coronavirus pandemic again highlighted the need for robust health care facility infection prevention and control (IPC) programmes. WHO guidelines on the core components (CCs) of IPC programmes provides guidance for facilities, but their implementation can be difficult to achieve in resource-limited settings. We aimed to gather evidence on an initial WHO IPC implementation experience using a mixed methods approach. METHODS A five-day training on the WHO IPC CCs was conducted at two reference acute health care facilities in the Democratic Republic of Congo and Burkina Faso. This was accompanied by a three-part mixed-methods evaluation consisting of a: (1) baseline and follow-up survey of participants' knowledge, attitudes and practices (KAP), (2) qualitative assessment of plenary discussion transcripts and (3) deployment of the WHO IPC assessment framework (IPCAF) tool. Results were analysed descriptively and with a qualitative inductive thematic approach. RESULTS Twenty-two and twenty-four participants were trained at each facility, respectively. Baseline and follow-up KAP results suggested increases in knowledge related to the necessity of a dedicated IPC focal person and annual evaluations of IPC training although lack of recognition on the importance of including hospital leadership in IPC training and hand hygiene monitoring recommendations remained. Most participants reported rarely attending IPC meetings or participating in IPC action planning although attitudes shifted towards stronger agreement with the feeling of IPC responsibility and importance of an IPC team. A reocurring theme in plenary discussions was related to limited resources as a barrier to IPC implementation, namely lack of reliable water access. However, participants recognised the importance of IPC improvement efforts such as practical IPC training methods or the use of data to improve quality of care. The facilities' IPCAF scores reflected a 'basic/intermediate' IPC implementation level. CONCLUSIONS The training and mixed methods evaluation revealed initial IPC implementation experiences that could be used to inform stepwise approaches to facility IPC improvement in resource-limited settings. Implementation strategies should consider both global standards such as the WHO IPC CCs and specific local contexts. The early involvement of all relevant stakeholders and parallel efforts to advocate for sufficient resources and health system infrastructure are critical.
Collapse
Affiliation(s)
- R Wood
- Robert Koch Institute, Berlin, Germany.
| | - W Tembele
- School of Public Health in Kinshasa, Hospital Saint Luc of Kisantu, Kisantu, Democratic Republic of Congo
| | - A Hema
- Centre Hospital University Sourou Sanou (CHUSS), Bobo-Dioulasso, Burkina Faso
| | - A Somé
- Centre Muraz, Bobo-Dioulasso, Burkina Faso
| | - E Kinganda-Lusamaki
- Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo
- Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of Congo
- Institute of Developmental Research, University of Montpellier, Montpellier, France
| | - C Basilubo
- Public health and Infection prevention control independent expert consultant, Kinshasa, Democratic Republic of Congo
| | - R Lumembe
- Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo
- Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of Congo
| | - N Alama
- Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo
- Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of Congo
| | - G Mbunsu
- Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo
- Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of Congo
| | - A Zongo
- Centre Muraz, Bobo-Dioulasso, Burkina Faso
| | - S Ahuka
- Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo
- Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of Congo
| | - J J Muyembe
- Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo
- Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of Congo
| | - F Leendertz
- Robert Koch Institute, Berlin, Germany
- Helmholtz Institute for One Health, Greifswald, Germany
| | | | | | - T Kagoné
- Centre Muraz, Bobo-Dioulasso, Burkina Faso
| | - S Makiala
- Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo
- Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Democratic Republic of Congo
| | - S Tomczyk
- Robert Koch Institute, Berlin, Germany
| |
Collapse
|
2
|
Ouédraogo AR, Bougma G, Baguiya A, Sawadogo A, Kaboré PR, Minougou CJ, Diendéré A, Maiga S, Agbaholou CR, Hema A, Sondo A, Ouédraogo G, Sanou A, Ouedraogo M. [Factors associated with the occurrence of acute respiratory distress and death in patients with COVID-19 in Burkina Faso]. Rev Mal Respir 2021; 38:240-248. [PMID: 33589360 PMCID: PMC7862901 DOI: 10.1016/j.rmr.2021.02.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2020] [Accepted: 12/16/2020] [Indexed: 11/08/2022]
Abstract
INTRODUCTION The development of acute respiratory distress syndrome indicates a serious form of COVID-19. Although there have been several studies on the prognostic factors of its severe form, no such study has been conducted in Burkina Faso. METHODS This was a retrospective cohort study conducted from March 9 to June 9, 2020 in Ouagadougou, Burkina Faso which involved 456 patients with COVID-19. RESULTS Nearly a quarter of the patients (23.2%) had presented with acute respiratory distress and 44.3% of them died. Being over 65 years old (HR: 2.7; 95% CI: 1.5-5.1) and having hypertension (HR: 1.9; 95% CI: 1-3.5) were independently associated with the risk of mortality. However, after adjustment, only age over 65 years (HR: 2.3; 95% CI: 1.2-4.3) was a risk factor for death. The survival rate for patients over 65 was 38.5% at 7 days and 30.3% at 15 days. CONCLUSIONS Acute respiratory distress leading to death is mainly found in older people with COVID-19. Close monitoring of these high-risk patients may reduce the risk of death.
Collapse
Affiliation(s)
- A R Ouédraogo
- Service de Pneumologie, Centre Hospitalier Universitaire de Tengandogo, Ouagadougou, Burkina Faso.
| | - G Bougma
- Service de Pneumologie, Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso
| | - A Baguiya
- Institut de Recherche en Sciences de la Santé, Unité de Surveillance Démographique et de Santé de Kaya, Burkina Faso
| | - A Sawadogo
- Service de maladies infectieuses et tropicales du Centre Hospitalier Universitaire Régional de Ouahigouya, Ouahigouya, Burkina Faso
| | - P R Kaboré
- Hôpital de district de Boulmiougou, Ouagadougou, Burkina Faso
| | - C J Minougou
- Service de Pneumologie, Centre Hospitalier Universitaire de Tengandogo, Ouagadougou, Burkina Faso
| | - A Diendéré
- Service de médecine interne, Centre Hospitalier Universitaire de Bogodogo, Ouagadougou, Burkina Faso
| | - S Maiga
- Service de maladies infectieuses et tropicales du Centre Hospitalier Universitaire Régional de Ouahigouya, Ouahigouya, Burkina Faso
| | - C R Agbaholou
- Service de Pneumologie, Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso
| | - A Hema
- Service de Pneumologie, Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso
| | - A Sondo
- Service de maladies infectieuses et tropicales, Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso
| | - G Ouédraogo
- Service de Pneumologie, Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso
| | - A Sanou
- Service de Chirurgie, Centre Hospitalier Universitaire de Tengandogo, Ouagadougou, Burkina Faso
| | - M Ouedraogo
- Service de Pneumologie, Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso
| |
Collapse
|
3
|
Hema A, Poda A, Tougouma JB, Meda C, Kabore F, Zoungrana J, Kamoule E, Sore I, Bado G, Ouedraogo AS, Sawadogo AB, Millogo A. [Diabetes mellitus and high blood pressure over risk in HIV-infected people followed at Souro Sanou University Hospital Day Hospital, Bobo-Dioulasso 2018]. Rev Epidemiol Sante Publique 2021; 69:72-77. [PMID: 33563493 DOI: 10.1016/j.respe.2020.12.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2020] [Revised: 11/24/2020] [Accepted: 12/10/2020] [Indexed: 12/30/2022] Open
Abstract
BACKGROUND Non-communicable diseases (NCDs) represent the leading causes of death worldwide. HIV also increases the risk of developing NCDs including diabetes mellitus and hypertension. METHODS A cross-sectional study, based on an analysis of the cohort database of the day hospital of the Souro Sanou teaching hospital in Bobo-Dioulasso (Burkina Faso). Diabetes mellitus was defined by the undergoing of anti-diabetic treatment or two successive measurements of fasting blood sugar above 7mmol/l and high blood pressure by the undergoing of antihypertensive treatment or two successive measurements of blood pressure above 140/90mmHg. Comparison of the frequency of diabetes and hypertension in the people living with HIV/AIDS (PLWHA) population on antiretroviral therapy (ART) with that of the general population of Burkina Faso was made by indirect standardization according to age and gender. RESULTS A total of 4259 patients including 3148 women (73.9%) were included in this study. The median age of the patients was 45 years (IQR: 38-52); the median body mass index (BMI) was 19.6kg/m2 (IQR: 15.4 - 22.7) and 48.3% of patients had a BMI≥25kg/m2. The median CD4 count was 590 cells/mm3 (IQR: 417-785). The median ART duration was 8.2 years (IQR: 4.7-11.2). The majority of patients (82.9%) were on treatment combinations consisting in 2 INTI+1 NNRTI. Prevalence of hypertension was 39.8%; it was statistically higher in men than in women (45.8% versus 37.8%). Prevalence of hypertension was 87.0% higher in the PLWHA population than among same-sex and same-age subjects in the general population. Prevalence of diabetes mellitus was 7.3%. Diabetes mellitus was more common in men than in women (10.1% versus 6.3%; P<10-3). Prevalence of diabetes mellitus was 36.0% higher in the PLWHA population than among same-sex and same-age subjects in the general population. CONCLUSION Prevalence of diabetes mellitus and hypertension was higher among PLHWA undergoing ART than in the general population. Care for the PLHWA population should more widely include NCD treatment.
Collapse
Affiliation(s)
- A Hema
- Hôpital de jour du service de maladies infectieuses, CHU Souro Sanou, 01 BP 676, Bobo-Dioulasso, Burkina Faso.
| | - A Poda
- Hôpital de jour du service de maladies infectieuses, CHU Souro Sanou, 01 BP 676, Bobo-Dioulasso, Burkina Faso; Institut national des sciences de la santé, Université Nazi Boni, Bobo-Dioulasso, Burkina Faso
| | - J-B Tougouma
- Service de cardiologie, CHU Souro Sanou, 01 BP 676, Bobo-Dioulasso, Burkina Faso; Institut national des sciences de la santé, Université Nazi Boni, Bobo-Dioulasso, Burkina Faso
| | - C Meda
- Institut national des sciences de la santé, Université Nazi Boni, Bobo-Dioulasso, Burkina Faso
| | - F Kabore
- Institut national de santé publique, Ouagadougou, Burkina Faso
| | - J Zoungrana
- Hôpital de jour du service de maladies infectieuses, CHU Souro Sanou, 01 BP 676, Bobo-Dioulasso, Burkina Faso; Institut national des sciences de la santé, Université Nazi Boni, Bobo-Dioulasso, Burkina Faso
| | - E Kamoule
- Service d'hépato-gastroentérologie, CHU Souro Sanou, 01 BP 676, Bobo-Dioulasso, Burkina Faso
| | - I Sore
- Hôpital de jour du service de maladies infectieuses, CHU Souro Sanou, 01 BP 676, Bobo-Dioulasso, Burkina Faso
| | - G Bado
- Hôpital de jour du service de maladies infectieuses, CHU Souro Sanou, 01 BP 676, Bobo-Dioulasso, Burkina Faso
| | - A-S Ouedraogo
- Hôpital de jour du service de maladies infectieuses, CHU Souro Sanou, 01 BP 676, Bobo-Dioulasso, Burkina Faso
| | - A-B Sawadogo
- Hôpital de jour du service de maladies infectieuses, CHU Souro Sanou, 01 BP 676, Bobo-Dioulasso, Burkina Faso
| | - A Millogo
- UFR/Sciences de la santé, Université Joseph Ki Zerbo, Ouagadougou, Burkina Faso
| |
Collapse
|
4
|
Zoungrana J, Kyelem CG, Sondo KA, Naibi KA, Hema A, Kabore NF, Poda A, Bado A, Yaméogo I, Séré H, Ouedraogo AS, Tani S, Tarnagda Z. [Characteristics of Low-Level Persistent viraemias in HIV-1 Patients Treated with Second-Line ARVs at the Sourô Sanou Teaching Hospital of Bobo-Dioulasso (Burkina Faso)]. ACTA ACUST UNITED AC 2019; 111:161-166. [PMID: 30793572 DOI: 10.3166/bspe-2018-0039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2017] [Accepted: 08/29/2018] [Indexed: 11/20/2022]
Abstract
We describe the characteristics of patients infected with HIV-1 as second-line antiretroviral therapy, with persisting low-level viremia. This was a descriptive retrospective study, conducted from January 1, 2010 to December 31, 2016, from the Cohort of the Infectious Diseases Department of Bobo-Dioulasso University Hospital. Patients infected with HIV-1, a second line of stable ARV treatment, with ≥95% compliance for at least 12 months, asymptomatic with CVp between 50 and 1000 copies/ml in two consecutive samplings at least 3 months apart. Out of 244 patients in second-line therapy, 79 met our inclusion criteria. The mean age of the patients was 42±10.2 years. Women (35.8 years) were younger than men (43.8 years) (p=0.001). Most were married (48.1%), 23.5% of whom were polygamous. The majority of patients (38/79) in the study had a CD4 count of <200 cells/ mm3. The median duration of ARV therapy since the beginning of the therapeutic history has been 4.8 (2.5-11 years). CVp greater than 10,000 copies/ml at the start of second-line therapy (p=0.003) and TDF+FTC + DRV + RTV combination (p=0.001) were associated with persistent low viremia. A genotypic resistance test is needed for these patients in order to better adapt the ARV treatment.
Collapse
Affiliation(s)
- J Zoungrana
- Service des maladies infectieuses du CHU Sanou Sourô Bobo-Dioulasso, Burkina Faso
| | - C G Kyelem
- Service de médecine interne du CHU Sanou Sourô Bobo-Dioulasso, Burkina Faso
| | - K A Sondo
- Service des maladies infectieuses du CHU Yalgado Ouedraogo de Ouagadougou, Burkina Faso
| | - K A Naibi
- Service des maladies infectieuses du CHU Sanou Sourô Bobo-Dioulasso, Burkina Faso
| | - A Hema
- Service des maladies infectieuses du CHU Sanou Sourô Bobo-Dioulasso, Burkina Faso
| | - N F Kabore
- Service des maladies infectieuses du CHU Sanou Sourô Bobo-Dioulasso, Burkina Faso
| | - A Poda
- Service des maladies infectieuses du CHU Sanou Sourô Bobo-Dioulasso, Burkina Faso
| | - A Bado
- Service de bactériologie virologie du CHU Sanou Sourô Bobo-Dioulasso, Burkina Faso
| | - I Yaméogo
- Service des maladies infectieuses du CHU Sanou Sourô Bobo-Dioulasso, Burkina Faso
| | - H Séré
- Service des maladies infectieuses du CHU Sanou Sourô Bobo-Dioulasso, Burkina Faso
| | - A S Ouedraogo
- Service de bactériologie virologie du CHU Sanou Sourô Bobo-Dioulasso, Burkina Faso
| | - S Tani
- Institut de recherche des sciences de la santé de Bobo-Dioulasso, Burkina Faso
| | - Z Tarnagda
- Institut de recherche des sciences de la santé de Bobo-Dioulasso, Burkina Faso
| |
Collapse
|
5
|
Testa J, Poda A, Hema A, Zoungrana J, Sore I, Kabore F, Meda N. Profil des patients âgés infectés par le VIH suivis à l’hôpital de jour de Bobo-Dioulasso. Rev Epidemiol Sante Publique 2016. [DOI: 10.1016/j.respe.2016.06.097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
6
|
Ouedraogo RA, Koala M, Dabire C, Hema A, Bazie VBEJT, Outtara LP, Gnoula C, Pale E, Nebie RHC. Teneur en phénols totaux et activité antioxydante des extraits des trois principales variétés d’oignons ( Allium cepa L.) cultivées dans la région du Centre-Nord du Burkina Faso. ACTA ACUST UNITED AC 2015. [DOI: 10.4314/ijbcs.v9i1.25] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
7
|
Ouedraogo SM, Zoungrana J, Sondo KA, Kyelem CG, Koussé S, Hema A, Kaboré FN, Soré I, Bado G, Sawadogo AB. [Immuno-virologic dissociation in patients infected by HIV-1 under antiretroviral treatment at the Day hospital of Bobo-Dioulasso from 2008 to 2012 (Burkina Faso)]. Mali Med 2015; 30:58-64. [PMID: 29927136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
OBJECTIVE describe the sociodemographic, clinical, therapeutic, biological profile and the observance of treatment in cases of immuno-virologic dissociation response (IVDR) in HIV-1 patients at te 12 months of antiretroviral treatment (ARVT). METHODS This was a historical cohort study with a descriptive and analytical focus from January 2008 to December 2012; covering the IVDR cases at the day hospital of Bobo Dioulasso. We collected the data during medical consultations by means of the ESOPE software and from medical records of the patients. RESULTS Of 2078 patients on ARVT, 84 or 4% presented one IVDR, among which 56 women (66.7%) and 28 men (33.3%). The average age was 45 years [range: 45-55 years]. At the initiation of ARVT, most patients were in clinical stage 3 or 4 of the WHO classification (57.1%). The body mass index (BMI) average was 20.5kg/m2 [IQR = 18.5 and 23]. The average number of +CD4 T lymphocyte was 42 cells/mm3 [IQR = 12- 63]. During follow-up, the median gain in BMI was 3.2 kg/m2 [IQR = 1.2 to 4.3 kg/m2], the median gain was 76 cells/µl [IQR = 60 - 88]. The viral plasmatic load of the HIV-1 was undetectable with a rate of TCD4+ < 100 cells /µl in 12 months. Factors associated with IVDR were the age between 35 and 45 years (p = 0.0009), the number of +CD4 T cells (+CD4T≤50) at initiation of ARVT (p = 0.00045 ) and the WHO classification clinical stage 3. CONCLUSION This study demonstrates the problem of IVDR management in Bobo-Dioulasso and reminds of the interest of care follow-up of people living with HIV-1 by viral load and not only by the rate of CD4+ T especially in the decentralized structures of coverage of HIV, where changes of therapeutic mechanisms operate disjointedly.
Collapse
Affiliation(s)
- S M Ouedraogo
- Université polytechnique de Bobo-Dioulasso, Institut Supérieur des Sciences de la santé, Bobo-Dioulasso
- Service de médecine interne du CHU Sourô Sanou, Bobo-Dioulasso, Burkina Faso
| | - J Zoungrana
- Université polytechnique de Bobo-Dioulasso, Institut Supérieur des Sciences de la santé, Bobo-Dioulasso
- Service des maladies infectieuses et de l'hôpital de jour du CHU Souro Sanou, Bobo-Dioulasso, Burkina Faso
| | - K A Sondo
- Université de Ouagadougou, Unité de Formation et de Recherche en Sciences de la santé (UFR/SDS)
- Services des maladies infectieuses du CHU Yalgado Ouédraogo, Ouagadougou, Burkina Faso
| | - C G Kyelem
- Université polytechnique de Bobo-Dioulasso, Institut Supérieur des Sciences de la santé, Bobo-Dioulasso
- Service de médecine interne du CHU Sourô Sanou, Bobo-Dioulasso, Burkina Faso
| | - S Koussé
- Service des maladies infectieuses et de l'hôpital de jour du CHU Souro Sanou, Bobo-Dioulasso, Burkina Faso
| | - A Hema
- Service des maladies infectieuses et de l'hôpital de jour du CHU Souro Sanou, Bobo-Dioulasso, Burkina Faso
| | - F N Kaboré
- Service des maladies infectieuses et de l'hôpital de jour du CHU Souro Sanou, Bobo-Dioulasso, Burkina Faso
| | - I Soré
- Service des maladies infectieuses et de l'hôpital de jour du CHU Souro Sanou, Bobo-Dioulasso, Burkina Faso
| | - G Bado
- Service des maladies infectieuses et de l'hôpital de jour du CHU Souro Sanou, Bobo-Dioulasso, Burkina Faso
| | - A B Sawadogo
- Service des maladies infectieuses et de l'hôpital de jour du CHU Souro Sanou, Bobo-Dioulasso, Burkina Faso
- Université de Ouagadougou, Unité de Formation et de Recherche en Sciences de la santé (UFR/SDS)
| |
Collapse
|
8
|
Zoungrana J, Hema A, Bado G, Poda GEA, Kamboulé EB, Kaboré FN, Soré I, Sawadogo AB. Efficacité et tolérance d’une trithérapie antirétrovirale à base de ténofovir disoproxil-emtricitabine-éfavirenz chez les patients naïfs infectés par le VIH-1 à Bobo Dioulasso (Burkina Faso, 2009–2011). ACTA ACUST UNITED AC 2013; 106:239-43. [DOI: 10.1007/s13149-013-0313-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2013] [Accepted: 09/10/2013] [Indexed: 01/09/2023]
|
9
|
Bado G, Penot P, N'Diaye MD, Amiel C, Hema A, Kamboulé EB, Guiard-Schmid JB, Kaboré NF, Slama L, Bambara A, Laurent C, Sangaré L, Sawadogo AB. Hepatitis B seroprevalence in HIV-infected patients consulting in a public day care unit in Bobo Dioulasso, Burkina Faso. Med Mal Infect 2013; 43:202-7. [PMID: 23701923 DOI: 10.1016/j.medmal.2013.04.001] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2011] [Revised: 02/21/2013] [Accepted: 04/16/2013] [Indexed: 10/26/2022]
Abstract
OBJECTIVE The authors had for aim to assess the prevalence of hepatitis B co-infection in a cohort of HIV-infected patients, routinely followed-up at the Day Care Unit of the Bobo Dioulasso Sanou Souro University Hospital, Burkina Faso. PATIENTS AND METHODS The Elisa technique was used to dose HBs antigen (AgHBs), antibodies anti-HBs and anti-HBc in all the patients followed by the biological laboratory, from October to December 2008. RESULTS The AgHBs prevalence was 12.7% [CI at 95%: 10.7-15.0%] and men were slightly more likely to be positive for AgHBs than women (16.5% [12.0-21.9%] versus 11.6% [9.4-14.1%]; P=0.047); 83.3% of the patients [80.8-85.6%] were positive for hepatitis B core antibody, and 32.6% [29.7-35.6%] for hepatitis B surface antibody; 29.9% of the patients [27.1-32.8%] had a complete profile of former hepatitis B infection, 41.3% [38.2-44.4%] expressed core antibodies only; 13.8% [11.7-16.0%] had a negative serological test, and 2.3% [1.5-3.4%] presented a vaccinal immunity. CONCLUSION These results stress the usefulness of screening for hepatitis B in all HIV-infected patients, along with the initial biological tests. This would help adapt HIV treatment to co-infected patients and to build an expanded program of vaccination for non-immune patients.
Collapse
Affiliation(s)
- G Bado
- Département de Médecine, Hôpital de Jour, CHU Souro Sanou Bobo Dioulasso, 01 BP 3437, Bobo Dioulasso, Burkina Faso.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Fontaine C, Hema A, Kamboule E, Guiard-Schmid JB, Lescure FX, Slama L, Pialoux G, Sawadogo A. L’hôpital de jour du CHU de Bobo Dioulasso : une structure de référence pour la prise en charge des patients infectés par le VIH au Burkina Faso. Med Mal Infect 2010; 40:393-7. [DOI: 10.1016/j.medmal.2009.10.018] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2008] [Revised: 04/03/2009] [Accepted: 10/29/2009] [Indexed: 11/16/2022]
|
11
|
Millogo A, Hare D, Hema A, Sessouma B. Les Polyneuropathies Chez Les Patients Infectés Par Le Vih À L\'ère Des Antirétroviraux Au Chu De Bobo-Dioulasso (Burkina Faso). African Journal of Neurological Sciences 2008. [DOI: 10.4314/ajns.v27i1.7612] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
12
|
Fontaine C, Sawadogo A, Slama L, Hema A, Traore I, Raguin G, Guiard-Schmid J. B-09 Bilan de 3 années du partenariat entre le SMIT du CHU de l’Hôpital Tenon (Paris) et le service de médecine interne du CHU Sanou Souro Bobo Dioulasso, Burkina Faso. Med Mal Infect 2008. [DOI: 10.1016/s0399-077x(08)73084-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
13
|
Millogo A, Hema A, Mare D, Sessouma B. O - 19 Les douleurs neuropathiques chez des patients infectés par le VIH à Bobo-Dioulasso (Burkina Faso). Rev Neurol (Paris) 2007. [DOI: 10.1016/s0035-3787(07)90735-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
14
|
Abstract
The concentrations of Cr, Pb, Zn, Cu, Ni and Cd were analyzed by Atomic Absorption Spectrophotometer in the scalp hair of professional male autodrivers who are occupationally exposed to the vehicular/industrial pollutants in the industrial city of Coimbatore, Tamil Nadu. The unwashed hair samples when compared with the washed hair showed a significantly higher levels of Cr, Zn and Pb. The correlation coefficient showed a strong mutual dependence on the scalp hair of the exposed individuals and no correlation was found among the trace metals except for Ni-Pb and Ni-Cd. The results in general showed a positive exogenous contribution of all the analyzed industrial trace metals. The drivers who are occupationally exposed to vehicular/industrial pollution are at risk.
Collapse
Affiliation(s)
- H Vishwanathan
- Department of Environmental Sciences, Bharathiar University, Coimbatore, Tamil Nadu, India.
| | | | | | | |
Collapse
|
15
|
Rajaguru P, Kalpana R, Hema A, Suba S, Baskarasethupathi B, Kumar PA, Kalaiselvi K. Genotoxicity of some sulfur dyes on tadpoles (Rana hexadactyla) measured using the comet assay. Environ Mol Mutagen 2001; 38:316-322. [PMID: 11774363 DOI: 10.1002/em.10027] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
This report presents the results of a genotoxicity study to evaluate the DNA damage caused by four sulfur dyes used in the textile and tannery industries. Alkaline single-cell gel electrophoresis assay (SCGE) was performed on erythrocytes from Rana hexadactyla tadpoles following whole-body exposure to increasing concentrations of the dyes. The dyes, along with their active ingredients, were Sandopel Basic Black BHLN, Negrosine, Dermapel Black FNI, and Turquoise Blue. The dye-treated tadpoles showed significant DNA damage, measured as mean DNA length:width ratio, when compared with unexposed control animals. Among the four tested dyes Sandopel Basic Black BHLN appears to be highly genotoxic, Dermapel Black FNI was least genotoxic, and Negrosine and Turquoise Blue were moderately toxic to R. hexadactyla tadpoles. The tadpoles showed a significant reduction in DNA damage when placed in dechlorinated tap water after exposure for a 24-hr period to the dye solutions.
Collapse
Affiliation(s)
- P Rajaguru
- Department of Environmental Science, PSG College of Arts and Science, Coimbatore 641014, India.
| | | | | | | | | | | | | |
Collapse
|